1. Home
  2. VYLR vs IDXX Comparison

VYLR vs IDXX Comparison

Compare VYLR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VYLR

Vylor Inc. Common Stock

N/A

Current Price

$74.39

Market Cap

52.2B

ML Signal

N/A

Logo IDEXX Laboratories Inc.

IDXX

IDEXX Laboratories Inc.

HOLD

Current Price

$562.99

Market Cap

45.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYLR
IDXX
Founded
1802
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2B
45.4B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
VYLR
IDXX
Price
$74.39
$562.99
Analyst Decision
Buy
Buy
Analyst Count
16
15
Target Price
$82.07
★ $702.38
AVG Volume (30 Days)
★ 4.7M
454.6K
Earning Date
11-11-2026
11-02-2026
Dividend Yield
★ 1.01%
N/A
EPS Growth
N/A
★ 22.59
EPS
N/A
★ 7.74
Revenue
N/A
★ $4,303,702,000.00
Revenue This Year
N/A
$9.77
Revenue Next Year
$3.56
$8.99
P/E Ratio
★ N/A
$73.11
Revenue Growth
N/A
★ 10.42
52 Week Low
$65.11
$500.61
52 Week High
$77.39
$769.98

Technical Indicators

Market Signals
Indicator
VYLR
IDXX
Relative Strength Index (RSI) 65.51 63.43
Support Level $71.20 $541.47
Resistance Level $76.13 $581.28
Average True Range (ATR) 2.80 11.86
MACD -0.12 5.09
Stochastic Oscillator 56.55 90.15

Price Performance

Historical Comparison
VYLR
IDXX

About VYLR Vylor Inc. Common Stock

Vylor is a seed and crop genetics pure-play company. The company was formed in 2026 when it was spun off from Corteva. Vylor is a leader in the development of genetically modified seeds and other advanced germplasm and traits that boost crop yields. The company operates in two segments based on geography—Americas and Rest of World. The Americas segment, which includes North and South America, generates most sales and profits.

About IDXX IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Share on Social Networks: